Eisai, a US pharmaceutical company, becomes one of the first to use Medidata's AI-driven Clinical Data Studio to enhance trials and control clinical data.
Medidata, a Dassault Systèmes brand, announced that Eisai, a U.S. pharmaceutical subsidiary, is one of the first customers to use its AI-driven Medidata Clinical Data Studio. Eisai aims to enhance patient experience, execute scalable and complex clinical trials, and gain control over its clinical data using the innovative solution. The AI-enhanced platform is expected to accelerate data review and reconciliation by 80%.
July 25, 2024
9 Articles